[1]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2006/127926,2006,A2Locationinpatent:Page/Pagecolumn77
[2]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2006/127926,2006,A2Locationinpatent:Page/Pagecolumn81
[3]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2006/127926,2006,A2Locationinpatent:Page/Pagecolumn78
[4]CurrentPatentAssignee:Novartis(w/oSandoz);NOVARTISAG-WO2006/127926,2006,A2Locationinpatent:Page/Pagecolumn77
Title: Trudel S, et al. CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma. Blood. 2005, 105(7), 2941-2948.
Title: Huynh H, et al. Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma. J Hepatol. 2012, 56(3), 595-601.